Central post-stroke pain (CPSP) is a neuropathic pain syndrome that often develops in a delayed manner after thalamic stroke. Here, we describe a new model of CPSP by stereotaxic thalamic injection of endothelin-1. Stroke rats (n = 12), but not saline-injected controls (n = 12), developed a progressive, contralateral cutaneous thermal hyperalgesia over 4 weeks, without motor deficits. Lesions were highly focal and mainly affected the ventral posterior thalamic complex. Tchis model reproduces the infarct location and delayed hypersensitivity typical of CPSP, and may be useful to investigate its pathophysiology and test therapies targeting recovery and pain after thalamic stroke.
INTRODUCTIONCentral post-stroke pain (CPSP) is a neuropathic pain syndrome characterized by constant or recurrent pain after central nervous system injury. 1 Central post-stroke pain can be triggered by either an ischemic or hemorrhagic infarct at any level of the spinothalamic pathway and its cortical projections often involving the thalamus. 2 Central post-stroke pain is frequently overlooked, and can be misdiagnosed as musculoskeletal pain resulting from paresis and/or muscle tone abnormalities. 3 Epidemiological data are scarce, probably because of the difficulty in interpreting the clinical signs and the variable symptom onset. Thus, CPSP is often perceived as a rare event. 4 However, the true incidence in stroke patients is as high as 8% to 11%. 5 The pathophysiology of CPSP is still poorly understood, and therapeutic options are limited in part owing to a lack of clinically relevant animal models. 6 For example, experimental CPSP models involving thalamic hemorrhage all show acute onset of the pain symptoms, 7,8 in contrast to the delayed onset of CPSP several weeks later in patients. 4 To address these shortcomings, we aimed to develop a new experimental model that better mimics the lateonset hypersensitivity seen in CPSP patients. Recently, two clinical reports linked CPSP to more posterior, inferior, and lateral thalamic infarcts, clustering at the ventral posterior thalamic nuclei. 9,10 These relay nuclei receive inputs from medial lemniscus, spinothalamic, and trigeminothalamic tracts, and project to the somatosensory cortex where noxious and non-painful, thermal, and mechanical stimuli are processed. We, therefore, targeted the ventral posterior thalamic complex by using stereotaxic microinjections of endothelin-1 to create highly focal ischemic lesions in rats.